One exception is a dual cancer drug trial that Merck and AstraZeneca announced last year.
After two decades of trying, drug firms have no replacement for the oft-used breast cancer drug.
And this research intersects with one of the hotter areas in cancer drug research.
Cancer drug Gleevec gives chronic myelogenous leukemia patients a 24-month survival rate of 92%.
Another big winner was Exelixis, which saw good results from its prostate cancer drug.
Prof Marais said the same effect is possible in other forms of targeted cancer drug treatment.
Genentech's breast cancer drug Herceptin works only in women whose cancer has a particular mutated gene.
The deal allows Amgen to regain rights to its cancer drug Vectibix in Brazil.
It's a variation on the well-established breast cancer drug Taxol, which works by inhibiting cell division.
FORBES: Patrick Soon-Shiong and one of cancer's biggest riddles.
Just because a cancer drug shows great results at ASCO doesn't guarantee its future.
The best colon cancer drug out there is a 50-year-old drug called 5FU, Saltz says.
Robust sales of the cancer drug Avastin lifted Genentech earnings in the third quarter.
The FDA has approved a breast cancer drug only for women with a particular genetic makeup.
FORBES: Can Personalized Healthcare Survive Obamacare's Medicine Assembly Line?
Finally, Novartis continues to fight to retain its legal rights to its cancer drug, Glivec.
Last week, Pfizer was denied its patent rights to its cancer drug, Sutent.
Erbb2, or Her2, is the target of breast cancer drug Herceptin from Roche and lapatinib from GlaxoSmithkline.
For a while, it was as if a new breakthrough cancer drug hit every year: Gleevec, Erbitux, Avastin.
India's patent office ordered Bayer, a German drugmaker, to license a cheaper version of Nexavar, an anti-cancer drug.
Abiraterone is dramatically different in several ways from another high-profile prostate cancer drug, Provenge, from Dendreon of Seattle.
Twenty-five years ago he laid scientific groundwork for the breast cancer drug Herceptin, which is now a blockbuster.
Which of the great minds behind the breakthrough cancer drug Avastin should win the Nobel Prize in Medicine?
In 1999 came another setback, when Novartis halted work on Isis' lung cancer drug, then in early-stage trials.
There could be another battle ahead, which could have implication for cancer drug companies like Novartis and Eli Lilly.
Now it hopes Afinitor will be its next cancer bestseller, says David Epstein, who leads Novartis' cancer drug business.
But in 2001 Clackson and his group started synthesizing an mTOR cancer drug that would sidestep the immune system.
Anji Reddy says he's negotiating licenses for several more cholesterol, diabetes and cancer drug molecules discovered in his laboratory.
If a safe cancer drug probably works, should the FDA risk approving it?
Now, this vital cancer drug is seen realistically as a very toxic but very necessary treatment for many cancers.
Lots more will be said about these and other cancer drug stocks as we get closer to the meeting.
应用推荐